Canadian life sciences & health tech companies will have the opportunity to pitch in person to global investors at the OBIO Investment Summit in Toronto on February 5-7, 2025. The Summit will highlight Canada’s most promising early-stage and venture-backed companies across a full spectrum of technologies: therapeutics, medical devices, diagnostics, digital health and health IT.
Conscience will be participating in the Early Technology Showcase along with Molecular Forecaster and Binary Star Research Services to highlight how we’re helping SMEs develop their products and services for AI and drug discovery.
